The most dangerous type -- multidrug-resistant tuberculosis or MDR-TB -- can't be cured by the usual rounds of antibiotics. But a new study finds significant success in new treatment options.

Provisional CDC guidelines cover FDA-approved and off-label uses of bedaquiline in children, pregnant women, or persons with extrapulmonary MDR TB, who were not included in clinical trials.

India has the maximum number of MDR-TB cases at 2.8 million every year. It is estimated that by 2040, 12.4% Indians will fall prey to the MDR pandemic and 1 in every 10 cases would be drug resistant.

Better diagnosis and treatment of multidrug-resistant and extensively drug-resistant tuberculosis strains are urgently needed, according to a paper published this week in The Lancet as part of a ...

Source: TB and MDR-TB data from the World Health Organization; population data from the World Bank. The map shows the latest data for each nation collected by the WHO, compared to the national ...

This year’s topic was Multi-Drug Resistant Tuberculosis (MDR-TB)–more about that in a minute. The venue provided a remarkable opportunity to reflect on the gaps between the promise and ...

TB can become drug-resistant in patients who don’t complete the proper treatment, and MDR-TB can also spread from patient to patient, infecting new people with the resistant strain.

As many as about 60 percent of patients started on treatment for multidrug-resistant tuberculosis (MDR-TB) will not be cured. With odds already stacked against them, Eastern Cape MDR-TB patients face ...

Already, the prevalence of MDR-TB among new patients is 2-3 per cent. In the case of previously treated patients, the prevalence is 11-17 per cent. Incidence (number of cases detected in a year ...

There’s encouraging news about treating multi-drug resistant tuberculosis, which killed about 210-thousand people last year. Preliminary data indicate a shorter, less painful treatment regimen ...

MDR-TB: A Healthcare Crisis of Our Own Design. Last month I attended the Pacific Health Summit in Seattle. It is a pretty exclusive venue (aspiring to be the “Davos of Health Care”) ...